A Scottish medical technology company will start clinical trials on a system that can provide real-time monitoring of muscle cells in the next few weeks.
Softcell Medical aims to bring its first product to the market in 2020. It consists of a single use probe, which is attached to a cannula to monitor pH levels of cells, with the data then fed back into a handheld device. The system is designed to give surgeons earlier warnings of muscle cell distress.
The system is to be used on patients in Aberdeen, Dundee, Edinburgh and Glasgow over the next few months. Alan Johnstone, a consultant orthopaedic surgeon at Aberdeen Royal Infirmary, has developed the technology.
Kirsty McIntosh, Softcell’s chief executive, said that the plan was to CE…